PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients

Peroxisome proliferator-activated receptors (PPAR), ligand-activated transcription factors of the nuclear hormone receptor superfamily, have been identified as key metabolic regulators in the liver, skeletal muscle, and adipose tissue, among others. As a leading cause of liver disease worldwide, non...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Naomi F., Graf, Vanessa, Caussy, Cyrielle, Dufour, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028563/
https://www.ncbi.nlm.nih.gov/pubmed/35457120
http://dx.doi.org/10.3390/ijms23084305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028563/
https://www.ncbi.nlm.nih.gov/pubmed/35457120
http://dx.doi.org/10.3390/ijms23084305

Ejemplares similares